Kyon Biotech AG – Trademark Portfolio
Entity Type: 09
Kyon Biotech AG holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include HEPIUS, ARGULIN, and ASPAREA. The owner is based in Zürich.
Hardturmstrasse 103
Zürich 8005 , CH
Showing of trademarks Trademarks
Trademark Classifications
Kyon Biotech AG's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Kyon Biotech AG have?
Kyon Biotech AG has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Kyon Biotech AG file in?
Kyon Biotech AG files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Kyon Biotech AG's most well-known trademarks?
Kyon Biotech AG's registered trademark portfolio includes well-known marks such as HEPIUS, ARGULIN, and ASPAREA. These are among 3 currently registered trademarks in the portfolio.
What is Kyon Biotech AG's trademark registration success rate?
Kyon Biotech AG has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.